Determination of genotoxic nitrosamines in Valsartan with gas chromatography and mass spectrometry
Aplikace | 2019 | Thermo Fisher ScientificInstrumentace
GC/MSD, HeadSpace, GC/SQ
ZaměřeníFarmaceutická analýza
VýrobceThermo Fisher Scientific
Klíčová slovavalsartan, ndma, fda, ndea, nitrosamines, suitability, sim, genotoxic, injection, dmf, thermo, dmso, timed, drug, scientific, solution, inlet, splitless, were, recommended, method, parameters, commercially, detection, analytical, dcm, test, headspace, prepared, liner, standard, nitrosodimethylamine, mode, transfer, line, dissolving, triplus, source, methods, incubation, final, using, according, used, couled, jinshui, weighinh, sample, described, quantification
Podobná PDF
Determination of genotoxic nitrosamines in Valsartan with gas chromatography and mass spectrometry
2019|Thermo Fisher Scientific|Aplikace
APPLICATION NOTE 21922 Determination of genotoxic nitrosamines in Valsartan with gas chromatography and mass spectrometry Authors Introduction Yanggang Zhang, Jinshui Che and Shen Wang Thermo Fisher Scientific, Shanghai, China Valsartan is a widely used anti-hypertensive drug known to reduce human…
Klíčová slova
valsartan, valsartanndma, ndmafda, fdandea, ndeanitrosamines, nitrosaminessuitability, suitabilitysim, simgenotoxic, genotoxicdmf, dmfinjection, injectionthermo, thermodmso, dmsodrug, drugtimed, timedscientific
Overcoming the challenges of nitrosamine impurities in drugs
2020|Thermo Fisher Scientific|Technické články
CASE STUDY 73263 Overcoming the challenges of nitrosamine impurities in drugs What pharmaceutical QA/QC laboratories need to know: Advanced GC-MS capabilities for cGMP nitrosamine testing Why we need to analyze nitrosamine impurities in drugs Unacceptable levels of nitrosamine impurities were…
Klíčová slova
min, minndma, ndmandea, ndeanitrosamine, nitrosamineneipa, neipatime, timetemperature, temperatureimpurities, impuritiesorbitrap, orbitrapaquisition, aquisitionmass, massexactive, exactivesource, sourceloop, loopkpa
Overcoming the challenges of nitrosamine impurities in drugs
2020|Thermo Fisher Scientific|Ostatní
CASE STUDY 73263 Overcoming the challenges of nitrosamine impurities in drugs What pharmaceutical QA/QC laboratories need to know: Advanced GC-MS capabilities for cGMP nitrosamine testing Why we need to analyze nitrosamine impurities in drugs Unacceptable levels of nitrosamine impurities were…
Klíčová slova
min, minndma, ndmandea, ndeanitrosamine, nitrosamineneipa, neipatime, timetemperature, temperatureimpurities, impuritiesorbitrap, orbitrapaquisition, aquisitionmass, massexactive, exactivesource, sourcekpa, kpaloop
Nitrosamine Impurities Application Guide - Confidently Detect and Quantify Mutagenic Impurities in APIs and Drug Products
2020|Agilent Technologies|PříručkyPrezentace
Nitrosamine Impurities Application Guide Confidently Detect and Quantify Mutagenic Impurities in APIs and Drug Products Sartan-Based Losartan Valsartan Candesartan Telmisartan Metformin Ranitidine Nitrosamines are formed by chemical reactions that occur during API manufacturing whether from starting materials, intermediates, reactants, reuse…
Klíčová slova
back, backndma, ndmaneipa, neipandea, ndeafda, fdandipa, ndipandba, ndbametformin, metforminnitrosamine, nitrosamineintroduction, introductionapi, apivalsartan, valsartanbest, bestquant, quantdichloromethan
